476 results
·
26ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 2
×
Hepatitis A Test (Antibody And Igm Antibody)
FDA Pre-Market Approval
FDA Class 2
·IMX(R) HAVAB
Enzyme Immunoassay, Tracrolimus
FDA Pre-Market Approval
FDA Class 2
·IMX TACROLIMUS II
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX PSA
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX PSA
Hepatitis A Test (Antibody And Igm Antibody)
FDA Pre-Market Approval
FDA Class 2
·IMX(R) HAVAB
Hepatitis A Test (Antibody And Igm Antibody)
FDA Pre-Market Approval
FDA Class 2
·IMX(R) HAVAB
Hepatitis A Test (Antibody And Igm Antibody)
FDA Pre-Market Approval
FDA Class 2
·IMX(R) HAVAB
Hepatitis A Test (Antibody And Igm Antibody)
FDA Pre-Market Approval
FDA Class 2
·IMX HAVAB-M
Enzyme Immunoassay, Tracrolimus
FDA Pre-Market Approval
FDA Class 2
·IMX TACROLIMUS II
Enzyme Immunoassay, Tracrolimus
FDA Pre-Market Approval
FDA Class 2
·IMX TACROLIMUS II
IDI-MRSA
FDA 510(k)
FDA Class 2
·Microbiology
DEXELA DEX TOP MAMMOGRAPHY WORKSTATION, MODEL MAMWKVI
FDA 510(k)
FDA Class 2
·Radiology
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·IMX AND AXSYM PSA
Kit, Test,Alpha-Fetoprotein For Testicular Cancer
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX AFP ASSAY
Enzyme Immunoassay, Tracrolimus
FDA Pre-Market Approval
FDA Class 2
·IMX TACROLIMUS II ASSAY
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX TOTAL PSA
Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX(R) PSA*
Enzyme Immunoassay, Tracrolimus
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX TACROLIMUS II
IMPEDIMED - EXTRACELLULAR FLUID ANALYZER MODEL: L-DEX U400
FDA 510(k)
FDA Class 2
·Cardiovascular
System, Test, Carcinoembryonic Antigen
FDA Pre-Market Approval
FDA Class 2
·ABBOTT IMX-CEA (LIST 3A33)